Group One Trading’s Sophiris Bio, Inc. SPHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-8,500
Closed -$7K 5827
2018
Q4
$7K Sell
8,500
-23,900
-74% -$47K ﹤0.01% 4417
2018
Q3
$90K Buy
32,400
+16,400
+103% +$46.7K ﹤0.01% 3607
2018
Q2
$45K Buy
16,000
+11,500
+256% +$34.2K ﹤0.01% 4019
2018
Q1
$9K Buy
4,500
+1,000
+29% +$2.17K ﹤0.01% 4366
2017
Q4
$8K Sell
3,500
-11,000
-76% -$23.9K ﹤0.01% 4464
2017
Q3
$31K Sell
14,500
-37,000
-72% -$76.7K ﹤0.01% 3874
2017
Q2
$113K Buy
51,500
+10,500
+26% +$25.7K ﹤0.01% 3037
2017
Q1
$116K Buy
41,000
+40,300
+5,757% +$110K ﹤0.01% 2880
2016
Q4
$2K Buy
+700
New +$1.98K ﹤0.01% 4288

Other funds holding SPHS

Group One Trading's SPHS Position: Q1 2020 in Review

Group One Trading sold out of Sophiris Bio, Inc. (SPHS) in Q1 2020, closing a stake of 4,594 shares — an estimated $2K sold.

Group One Trading first reported a position in SPHS in Q1 2017 and held it in 9 quarters. The position peaked at $43K in Q2 2017. 3 funds tracked by Wall St. Rank hold SPHS as of Q1 2020.

  • Group One Trading reported no remaining Sophiris Bio, Inc. position as of Q1 2020 after selling out during the quarter.
  • Group One Trading sold 4,594 Sophiris Bio, Inc. shares in Q1 2020, an estimated $2K.
  • Group One Trading first reported a position in Sophiris Bio, Inc. in Q1 2017 and held it in 9 quarters.
  • Group One Trading's Sophiris Bio, Inc. position peaked at $43K in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2020.

Based on Group One Trading's 13F filing for Q1 2020, filed 13 May 2020.